Literature DB >> 18955972

Caspase-independent cell death: leaving the set without the final cut.

S W G Tait1, D R Green.   

Abstract

Apoptosis is dependent upon caspase activation leading to substrate cleavage and, ultimately, cell death. Although required for the apoptotic phenotype, it has become apparent that cells frequently die even when caspase function is blocked. This process, termed caspase-independent cell death (CICD), occurs in response to most intrinsic apoptotic cues, provided that mitochondrial outer membrane permeabilization has occurred. Death receptor ligation can also trigger a form of CICD termed necroptosis. In this review, we will examine the molecular mechanisms governing CICD, highlight recent findings demonstrating recovery from conditions of CICD and discuss potential pathophysiological functions of these processes.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18955972      PMCID: PMC2635930          DOI: 10.1038/onc.2008.311

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  101 in total

Review 1.  Caspase-independent cell death in T lymphocytes.

Authors:  Marja Jäättelä; Jürg Tschopp
Journal:  Nat Immunol       Date:  2003-05       Impact factor: 25.606

2.  Nobel lecture. Worms, life and death.

Authors:  H Robert Horvitz
Journal:  Biosci Rep       Date:  2003 Oct-Dec       Impact factor: 3.840

3.  Mitochondrial release of AIF and EndoG requires caspase activation downstream of Bax/Bak-mediated permeabilization.

Authors:  Damien Arnoult; Brigitte Gaume; Mariusz Karbowski; Juanita C Sharpe; Francesco Cecconi; Richard J Youle
Journal:  EMBO J       Date:  2003-09-01       Impact factor: 11.598

4.  Inhibition of papain-like cysteine proteases and legumain by caspase-specific inhibitors: when reaction mechanism is more important than specificity.

Authors:  J Rozman-Pungercar; N Kopitar-Jerala; M Bogyo; D Turk; O Vasiljeva; I Stefe; P Vandenabeele; D Brömme; V Puizdar; M Fonović; M Trstenjak-Prebanda; I Dolenc; V Turk; B Turk
Journal:  Cell Death Differ       Date:  2003-08       Impact factor: 15.828

5.  Lack of Apaf-1 expression confers resistance to cytochrome c-driven apoptosis in cardiomyocytes.

Authors:  D Sanchis; M Mayorga; M Ballester; J X Comella
Journal:  Cell Death Differ       Date:  2003-09       Impact factor: 15.828

6.  Regulation of an ATG7-beclin 1 program of autophagic cell death by caspase-8.

Authors:  Li Yu; Ajjai Alva; Helen Su; Parmesh Dutt; Eric Freundt; Sarah Welsh; Eric H Baehrecke; Michael J Lenardo
Journal:  Science       Date:  2004-05-06       Impact factor: 47.728

7.  Loss of Omi mitochondrial protease activity causes the neuromuscular disorder of mnd2 mutant mice.

Authors:  Julie M Jones; Pinaki Datta; Srinivasa M Srinivasula; Weizhen Ji; Sanjeev Gupta; ZhiJia Zhang; Erika Davies; György Hajnóczky; Thomas L Saunders; Margaret L Van Keuren; Teresa Fernandes-Alnemri; Miriam H Meisler; Emad S Alnemri
Journal:  Nature       Date:  2003-10-08       Impact factor: 49.962

8.  Allelic imbalance of 12q22-23 associated with APAF-1 locus correlates with poor disease outcome in cutaneous melanoma.

Authors:  Akihide Fujimoto; Hiroya Takeuchi; Bret Taback; Eddy C Hsueh; David Elashoff; Donald L Morton; Dave S B Hoon
Journal:  Cancer Res       Date:  2004-03-15       Impact factor: 12.701

9.  Apaf-1 and caspase-9 do not act as tumor suppressors in myc-induced lymphomagenesis or mouse embryo fibroblast transformation.

Authors:  Clare L Scott; Martin Schuler; Vanessa S Marsden; Alex Egle; Marc Pellegrini; Dobrila Nesic; Steve Gerondakis; Stephen L Nutt; Douglas R Green; Andreas Strasser
Journal:  J Cell Biol       Date:  2004-01-05       Impact factor: 10.539

10.  Critical function of endogenous XIAP in regulating caspase activation during sympathetic neuronal apoptosis.

Authors:  Patrick Ryan Potts; Shweta Singh; Malia Knezek; Craig B Thompson; Mohanish Deshmukh
Journal:  J Cell Biol       Date:  2003-11-17       Impact factor: 10.539

View more
  110 in total

Review 1.  Mitochondria and cell signalling.

Authors:  Stephen W G Tait; Douglas R Green
Journal:  J Cell Sci       Date:  2012-02-15       Impact factor: 5.285

Review 2.  Non-caspase proteases: triggers or amplifiers of apoptosis?

Authors:  Karen Schrader; Jisen Huai; Lars Jöckel; Carolin Oberle; Christoph Borner
Journal:  Cell Mol Life Sci       Date:  2010-02-19       Impact factor: 9.261

3.  Pathways involved in interleukin-1β-mediated murine cardiomyocyte apoptosis.

Authors:  Yi Shen; Jie Qin; Peili Bu
Journal:  Tex Heart Inst J       Date:  2015-04-01

4.  Spectral imaging-based methods for quantifying autophagy and apoptosis.

Authors:  Nathan G Dolloff; Xiahong Ma; David T Dicker; Robin C Humphreys; Lin Z Li; Wafik S El-Deiry
Journal:  Cancer Biol Ther       Date:  2011-08-15       Impact factor: 4.742

Review 5.  Mitochondrial regulation of cell death.

Authors:  Stephen W G Tait; Douglas R Green
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-09-01       Impact factor: 10.005

6.  Dual mechanisms of sHA 14-1 in inducing cell death through endoplasmic reticulum and mitochondria.

Authors:  David Hermanson; Sadiya N Addo; Anna A Bajer; Jonathan S Marchant; Sonia Goutam Kumar Das; Balasubramanian Srinivasan; Fawaz Al-Mousa; Francesco Michelangeli; David D Thomas; Tucker W Lebien; Chengguo Xing
Journal:  Mol Pharmacol       Date:  2009-06-26       Impact factor: 4.436

Review 7.  Mitochondrial control of caspase-dependent and -independent cell death.

Authors:  Ludivine A Pradelli; Marie Bénéteau; Jean-Ehrland Ricci
Journal:  Cell Mol Life Sci       Date:  2010-02-12       Impact factor: 9.261

8.  Docetaxel-induced prostate cancer cell death involves concomitant activation of caspase and lysosomal pathways and is attenuated by LEDGF/p75.

Authors:  Melanie Mediavilla-Varela; Fabio J Pacheco; Frankis Almaguel; Jossymar Perez; Eva Sahakian; Tracy R Daniels; Lai Sum Leoh; Amelia Padilla; Nathan R Wall; Michael B Lilly; Marino De Leon; Carlos A Casiano
Journal:  Mol Cancer       Date:  2009-08-28       Impact factor: 27.401

9.  The synthetic inhibitor of fibroblast growth factor receptor PD166866 controls negatively the growth of tumor cells in culture.

Authors:  Gianfranco Risuleo; Marina Ciacciarelli; Mauro Castelli; Gaspare Galati
Journal:  J Exp Clin Cancer Res       Date:  2009-12-11

10.  A novel chalcone derivative which acts as a microtubule depolymerising agent and an inhibitor of P-gp and BCRP in in-vitro and in-vivo glioblastoma models.

Authors:  Ahcene Boumendjel; Anne McLeer-Florin; Pierre Champelovier; Diane Allegro; Dima Muhammad; Florence Souard; Madiha Derouazi; Vincent Peyrot; Bertrand Toussaint; Jean Boutonnat
Journal:  BMC Cancer       Date:  2009-07-20       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.